GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
01 May 2012 05:40 PM
RNS
Transaction in Own Shares
01 May 2012 02:40 PM
RNS
Total Voting Rights
30 Apr 2012 05:03 PM
RNS
Transaction in Own Shares
30 Apr 2012 04:20 PM
RNS
Director/PDMR Shareholding
30 Apr 2012 01:03 PM
RNS
Director/PDMR Shareholding
27 Apr 2012 05:04 PM
RNS
Transaction in Own Shares
27 Apr 2012 12:47 PM
RNS
Director/PDMR Shareholding
26 Apr 2012 05:18 PM
RNS
Transaction in Own Shares
26 Apr 2012 12:02 PM
RNS
Director/PDMR Shareholding
25 Apr 2012 12:00 PM
RNS
1st Quarter Results
20 Apr 2012 04:10 PM
RNS
Director/PDMR Shareholding (Replacement)
20 Apr 2012 03:50 PM
RNS
Director/PDMR Shareholding
20 Apr 2012 03:38 PM
RNS
Director/PDMR Shareholding
20 Apr 2012 02:46 PM
RNS
Director/PDMR Shareholding
20 Apr 2012 12:30 PM
RNS
GSK update on divestment of non-core OTC brands
19 Apr 2012 04:00 PM
RNS
Director/PDMR Shareholding
19 Apr 2012 12:42 PM
RNS
GSK confirms offer to acquire HGS
18 Apr 2012 04:26 PM
RNS
Director/PDMR Shareholding
18 Apr 2012 04:23 PM
RNS
Director/PDMR Shareholding
18 Apr 2012 03:40 PM
RNS
Director/PDMR Shareholding
18 Apr 2012 03:35 PM
RNS
Director/PDMR Shareholding
18 Apr 2012 03:27 PM
RNS
Director/PDMR Shareholding
16 Apr 2012 06:11 PM
RNS
Director/PDMR Shareholding (Replacement)
16 Apr 2012 03:54 PM
RNS
Director/PDMR Shareholding
16 Apr 2012 12:23 PM
RNS
Director/PDMR Shareholding
16 Apr 2012 11:14 AM
RNS
Director/PDMR Shareholding
16 Apr 2012 11:09 AM
RNS
Director/PDMR Shareholding
13 Apr 2012 04:49 PM
RNS
Director/PDMR Shareholding
13 Apr 2012 04:46 PM
RNS
Director/PDMR Shareholding
13 Apr 2012 04:43 PM
RNS
Director/PDMR Shareholding
13 Apr 2012 04:25 PM
RNS
Director/PDMR Shareholding
03 Apr 2012 07:00 AM
RNS
GSK receives further phase 3 data for albiglutide
02 Apr 2012 05:22 PM
RNS
Director/PDMR Shareholding
02 Apr 2012 05:17 PM
RNS
Director/PDMR Shareholding
02 Apr 2012 05:10 PM
RNS
Director/PDMR Shareholding
02 Apr 2012 12:29 PM
RNS
GSK to increase its ownership in Theravance
02 Apr 2012 12:08 PM
RNS
Total Voting Rights
02 Apr 2012 07:00 AM
RNS
Phase lll study of dolutegravir in HIV announced
28 Mar 2012 04:55 PM
RNS
Transaction in Own Shares
27 Mar 2012 05:04 PM
RNS
Transaction in Own Shares
26 Mar 2012 05:17 PM
RNS
Transaction in Own Shares
26 Mar 2012 02:43 PM
RNS
Notice of AGM
23 Mar 2012 05:06 PM
RNS
Transaction in Own Shares
23 Mar 2012 11:03 AM
RNS
Annual Information Update
22 Mar 2012 11:19 AM
RNS
Director/PDMR Shareholding
19 Mar 2012 04:02 PM
RNS
Director/PDMR Shareholding
16 Mar 2012 05:05 PM
RNS
Transaction in Own Shares
15 Mar 2012 05:33 PM
RNS
Transaction in Own Shares
15 Mar 2012 09:30 AM
RNS
GSK update on divestment of non-core OTC brands
14 Mar 2012 05:09 PM
RNS
Transaction in Own Shares

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

UK 100

Latest directors dealings